Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Atanu Chakraborty

1PUBLICATIONS
20CO-AUTHORS
Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (1)

Sort by Publication Date:
|Aug 05, 2022
AZD4625 is a Potent and Selective Inhibitor of KRASG12C.

Atanu Chakraborty, Lyndsey Hanson, David Robinson

Pageof 1

Frequent Collaborators

1 joint publications

Lyndsey Hanson

1 joint publications

David Robinson

1 joint publications

Hilary Lewis

1 joint publications

Sue Bickerton

1 joint publications

Michael Davies

1 joint publications

Radoslaw Polanski

1 joint publications

Rebecca Whiteley

1 joint publications

Alex Koers

1 joint publications

James Atkinson

1 joint publications

Tamara Baker

Frequent Collaborators

1 joint publications

Lyndsey Hanson

1 joint publications

David Robinson

1 joint publications

Hilary Lewis

1 joint publications

Sue Bickerton

Top Related Videos

Development and Maintenance of a Preclinical Patient Derived Tumor Xenograft Model for the Investigation of Novel Anti-Cancer Therapies
09:29

Development and Maintenance of a Preclinical Patient Derived Tumor Xenograft Model for the Investigation of Novel Anti-Cancer Therapies

Published on : Sep 30, 2016

13.9K
See more related videos

Top Related Videos

Development and Maintenance of a Preclinical Patient Derived Tumor Xenograft Model for the Investigation of Novel Anti-Cancer Therapies
09:29

Development and Maintenance of a Preclinical Patient Derived Tumor Xenograft Model for the Investigation of Novel Anti-Cancer Therapies

Published on : Sep 30, 2016

13.9K
See more related videos